ADVANCING ON THE
PATHWAY OF DISCOVERY
World Congress on Psychiatric Genetics XIII

October 14 - 18, 2005
Boston, MA
The Westin Copley Place

Keynote Plenary Session Speakers

• David Bartel, Ph.D.
  Member, Whitehead Institute, Professor of Biology, MIT, and Investigator of the Howard Hughes Medical Institute
• Eric Lander, Ph.D.
  Director, Broad Institute of MIT and Harvard
• Nick Craddock, Ph.D.
  Professor of Psychiatry at Cardiff University, Wales, UK
• Pasko Rakic, M.D., Ph.D.
  Professor and Chairman of Neurobiology, Yale University School of Medicine
• Edward Scolnick, M.D.
  Director of the Psychiatric Disease Initiative at Broad Institute
• Nora Volkow, M.D.
  Director, National Institute on Drug Abuse (NIDA)
  

 Special Forums

Saturday, October 15
10:00 AM - 11:45 AM
Plenary Session Designed for Extensive Audience Participation:
Avoiding False Candidate Gene Findings: Can We Set a Standard for the Field?

America Ballroom 1-2-3 - Special Forum

Chaired by:

• Professor Lynn Delisi, M.D., Associate Director, Center for Advanced Brain Imaging, The Nathan S Kline Institute for Psychiatric Research.
• Stephen V. Faraone, Ph. D., Director, Medical Genetics Research and Professor, Department of Psychiatry, SUNY Upstate Medical University

Participation by:

• Nancy J. Cox, Ph.D., Dept of Human Genetics, University of Chicago
• Dr. Kathleen Merikangas, National Institute of Mental Health (NIMH), Bethesda, MD
• Mark Daly, PhD, The Broad Institute, Boston, MA
• James Kennedy, MD, Centre for Addiction and Mental Health

In the first hour of this symposium speakers will address the following questions: Is the pathway to discovery obscured by many false positive and negative findings? How should authors correct for multiple comparisons when testing many SNPs and halotypes in the same gene? What criteria should the field use to decide that the cumulative results of many studies implicate a gene in the etiology of a disorder or trait? What guidelines should editors use when reviewing a manuscript that concludes a polymorphism is associated with a disorder or trait?

Sunday, October 16
09:45 AM - 11:30 AM
Has Psychiatric Genetics Found Pathways to Discovery? A Plenary Debate

America Ballroom 1-2-3 - Special Forum

Chaired by:

• Stephen V. Faraone, Ph. D., Director, Medical Genetics Research and Professor, Department of Psychiatry, SUNY Upstate Medical University
• Professor. Lynn Delisi, M.D., Associate Director, Center for Advanced Brain Imaging, The Nathan S Kline Institute for Psychiatric Research.

This plenary will take the form of a debate, with one presentation representing the position that psychiatric genetics has strayed from the pathway to discovery and a second representing the opposite view. These points will be summarized and discussed, then followed by one hour of questions and discussion from the audience.

Participation by:

• Tom Insel, MD, Director, US National Institute of Mental Health, Bethesda, MD
• John Hardy, Ph.D., Senior Investigator, National Institute of Health, Bethesda, MD
• Mike Owen is Chairman of the Department of Psychiatry, University of Cardiff, Cardiff, Wales, U.K.

 Concurrent Oral Sessions: (20) 120 Minute Sessions

• Anxiety Disorders: Of Mice and Men
• Anxious/Depression: The Hunt for Genetic Influence
• Association Studies of Bipolar Affective Disorder
• Attention Deficit Hyperactivity Disorder (ADHD): Genotypes, Phenotypes and
• Can Genetic Variation be Imaged?
• The Kraepelin Dichotomy—Dead or Alive?
• Frontiers in Statistical Methods
• Roles of Gene Expression in Understanding Major Mental Disorders
• Genetic Memory and Dyslexia
• Genetic Studies of Alcohol and Illicit Drug Use
• Genetic Studies of Developmental Psychopathology
• Genetic Studies of Smoking and Co-Morbidity
• Linkage Studies of Bipolar Affective Disorder
• Molecular Genetics of Human Cognition
• Novel Analytic Approaches to Gene Discovery
• Pharmacogenetics
• Schizophrenia 1
• Schizophrenia 2

 Poster Sessions: (3) 90 Minutes Sessions

• Over 450 Posters covering
• 20 + Topics
• Late Breaking Section

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of SUNY Upstate Medical University and International Society of Psychiatric Genetics. SUNY Upstate Medical University is accredited by the ACCME to provide continuing medical education for physicians.

SUNY Upstate Medical University designates this continuing medical education activity for a maximum of 27.50 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.